305 related articles for article (PubMed ID: 12051714)
1. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
Hagen T; Vidal-Puig A
Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
[TBL] [Abstract][Full Text] [Related]
2. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
[TBL] [Abstract][Full Text] [Related]
3. beta-catenin is a target for the ubiquitin-proteasome pathway.
Aberle H; Bauer A; Stappert J; Kispert A; Kemler R
EMBO J; 1997 Jul; 16(13):3797-804. PubMed ID: 9233789
[TBL] [Abstract][Full Text] [Related]
4. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
[TBL] [Abstract][Full Text] [Related]
5. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
6. Threonine 41 in beta-catenin serves as a key phosphorylation relay residue in beta-catenin degradation.
Wu G; He X
Biochemistry; 2006 Apr; 45(16):5319-23. PubMed ID: 16618120
[TBL] [Abstract][Full Text] [Related]
7. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
Jho Eh; Lomvardas S; Costantini F
Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
[TBL] [Abstract][Full Text] [Related]
8. Identification of two novel regulated serines in the N terminus of beta-catenin.
van Noort M; van de Wetering M; Clevers H
Exp Cell Res; 2002 Jun; 276(2):264-72. PubMed ID: 12027456
[TBL] [Abstract][Full Text] [Related]
9. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K
Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688
[TBL] [Abstract][Full Text] [Related]
10. Axin prevents Wnt-3a-induced accumulation of beta-catenin.
Kishida M; Koyama S; Kishida S; Matsubara K; Nakashima S; Higano K; Takada R; Takada S; Kikuchi A
Oncogene; 1999 Jan; 18(4):979-85. PubMed ID: 10023673
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterization of GSK-3 mutants and their effect on beta-catenin phosphorylation in intact cells.
Hagen T; Di Daniel E; Culbert AA; Reith AD
J Biol Chem; 2002 Jun; 277(26):23330-5. PubMed ID: 11967263
[TBL] [Abstract][Full Text] [Related]
12. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J
EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation and ubiquitination of oncogenic mutants of beta-catenin containing substitutions at Asp32.
Al-Fageeh M; Li Q; Dashwood WM; Myzak MC; Dashwood RH
Oncogene; 2004 Jun; 23(28):4839-46. PubMed ID: 15064718
[TBL] [Abstract][Full Text] [Related]
14. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
Takahashi M; Yasutake K; Tomizawa K
J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
[TBL] [Abstract][Full Text] [Related]
15. Sporadic medulloblastomas contain oncogenic beta-catenin mutations.
Zurawel RH; Chiappa SA; Allen C; Raffel C
Cancer Res; 1998 Mar; 58(5):896-9. PubMed ID: 9500446
[TBL] [Abstract][Full Text] [Related]
16. Human serum and glucocorticoid-inducible kinase-like kinase (SGKL) phosphorylates glycogen syntheses kinase 3 beta (GSK-3beta) at serine-9 through direct interaction.
Dai F; Yu L; He H; Chen Y; Yu J; Yang Y; Xu Y; Ling W; Zhao S
Biochem Biophys Res Commun; 2002 May; 293(4):1191-6. PubMed ID: 12054501
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum.
Alimohamad H; Rajakumar N; Seah YH; Rushlow W
Biol Psychiatry; 2005 Mar; 57(5):533-42. PubMed ID: 15737669
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction: signaling specificity- a complex affair.
Weston CR; Davis RJ
Science; 2001 Jun; 292(5526):2439-40. PubMed ID: 11431552
[No Abstract] [Full Text] [Related]
19. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.
Ding Q; Xia W; Liu JC; Yang JY; Lee DF; Xia J; Bartholomeusz G; Li Y; Pan Y; Li Z; Bargou RC; Qin J; Lai CC; Tsai FJ; Tsai CH; Hung MC
Mol Cell; 2005 Jul; 19(2):159-70. PubMed ID: 16039586
[TBL] [Abstract][Full Text] [Related]
20. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.
Amit S; Hatzubai A; Birman Y; Andersen JS; Ben-Shushan E; Mann M; Ben-Neriah Y; Alkalay I
Genes Dev; 2002 May; 16(9):1066-76. PubMed ID: 12000790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
